Cargando…

A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis

Non-alcoholic fatty liver disease (NAFLD) has a high prevalence worldwide, with a significant proportion of patients progressing into non-alcoholic steatohepatitis (NASH) and further into cirrhosis and hepatocellular carcinoma (HCC). Most of the current animal models of NASH have limitations, such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuecheng, Lu, Yi, Liang, Xiaoshuang, Zhou, Xiaofei, Li, Dirui, Zhang, Zan, Niu, Yunchao, Liu, Shuaishuai, Ye, Ling, Zhang, Rufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212180/
https://www.ncbi.nlm.nih.gov/pubmed/37228085
http://dx.doi.org/10.1371/journal.pone.0286257
_version_ 1785047412193099776
author Li, Xuecheng
Lu, Yi
Liang, Xiaoshuang
Zhou, Xiaofei
Li, Dirui
Zhang, Zan
Niu, Yunchao
Liu, Shuaishuai
Ye, Ling
Zhang, Rufeng
author_facet Li, Xuecheng
Lu, Yi
Liang, Xiaoshuang
Zhou, Xiaofei
Li, Dirui
Zhang, Zan
Niu, Yunchao
Liu, Shuaishuai
Ye, Ling
Zhang, Rufeng
author_sort Li, Xuecheng
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) has a high prevalence worldwide, with a significant proportion of patients progressing into non-alcoholic steatohepatitis (NASH) and further into cirrhosis and hepatocellular carcinoma (HCC). Most of the current animal models of NASH have limitations, such as incompatibility with human pathogenesis characteristics or long induction periods, which severely limit the development of new drugs and preclinical studies for NASH. We investigated the progression of NASH and fibrosis, as well as metabolic indicators, at different time points in aged mice induced by the Gubra Amylin NASH (GAN) diet, a high-fat, high-sugar, high-cholesterol diet, and attempted to establish a rapid and useful mouse model of NASH. Young and aged C57BL/6 mice were induced on a normal chow or GAN diet for 12 and 21 weeks, respectively. After 12 weeks of induction, aged mice developed NASH, including hepatic steatosis, lobular inflammation and hepatic ballooning, and the phenotype was more severe compared with young mice. After 21 weeks of induction, aged mice developed hepatic fibrosis, which greatly shortened the induction time compared with young mice. Furthermore, analysis of immune cell infiltration in the liver by flow cytometry elucidated the changes of multiple immune cells during the pathogenesis of NASH. These findings suggest that aged mice may develop NASH and fibrosis more rapidly under GAN diet induction, which may significantly shorten the period for preclinical studies of NASH.
format Online
Article
Text
id pubmed-10212180
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-102121802023-05-26 A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis Li, Xuecheng Lu, Yi Liang, Xiaoshuang Zhou, Xiaofei Li, Dirui Zhang, Zan Niu, Yunchao Liu, Shuaishuai Ye, Ling Zhang, Rufeng PLoS One Research Article Non-alcoholic fatty liver disease (NAFLD) has a high prevalence worldwide, with a significant proportion of patients progressing into non-alcoholic steatohepatitis (NASH) and further into cirrhosis and hepatocellular carcinoma (HCC). Most of the current animal models of NASH have limitations, such as incompatibility with human pathogenesis characteristics or long induction periods, which severely limit the development of new drugs and preclinical studies for NASH. We investigated the progression of NASH and fibrosis, as well as metabolic indicators, at different time points in aged mice induced by the Gubra Amylin NASH (GAN) diet, a high-fat, high-sugar, high-cholesterol diet, and attempted to establish a rapid and useful mouse model of NASH. Young and aged C57BL/6 mice were induced on a normal chow or GAN diet for 12 and 21 weeks, respectively. After 12 weeks of induction, aged mice developed NASH, including hepatic steatosis, lobular inflammation and hepatic ballooning, and the phenotype was more severe compared with young mice. After 21 weeks of induction, aged mice developed hepatic fibrosis, which greatly shortened the induction time compared with young mice. Furthermore, analysis of immune cell infiltration in the liver by flow cytometry elucidated the changes of multiple immune cells during the pathogenesis of NASH. These findings suggest that aged mice may develop NASH and fibrosis more rapidly under GAN diet induction, which may significantly shorten the period for preclinical studies of NASH. Public Library of Science 2023-05-25 /pmc/articles/PMC10212180/ /pubmed/37228085 http://dx.doi.org/10.1371/journal.pone.0286257 Text en © 2023 Li et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Li, Xuecheng
Lu, Yi
Liang, Xiaoshuang
Zhou, Xiaofei
Li, Dirui
Zhang, Zan
Niu, Yunchao
Liu, Shuaishuai
Ye, Ling
Zhang, Rufeng
A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
title A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
title_full A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
title_fullStr A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
title_full_unstemmed A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
title_short A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis
title_sort new nash model in aged mice with rapid progression of steatohepatitis and fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212180/
https://www.ncbi.nlm.nih.gov/pubmed/37228085
http://dx.doi.org/10.1371/journal.pone.0286257
work_keys_str_mv AT lixuecheng anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT luyi anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT liangxiaoshuang anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT zhouxiaofei anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT lidirui anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT zhangzan anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT niuyunchao anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT liushuaishuai anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT yeling anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT zhangrufeng anewnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT lixuecheng newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT luyi newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT liangxiaoshuang newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT zhouxiaofei newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT lidirui newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT zhangzan newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT niuyunchao newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT liushuaishuai newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT yeling newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis
AT zhangrufeng newnashmodelinagedmicewithrapidprogressionofsteatohepatitisandfibrosis